Moving Forward With Treatment of Gonorrhea for Users of Human Immunodeficiency Virus Preexposure Prophylaxis Given the Threat of Antimicrobial Resistance

Affiliations

¹ Department of Epidemiology, Emory University, Atlanta, Georgia.
² Department of Anthropology, University of Washington, Seattle.
³ Division of STD Prevention and Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
⁴ Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
⁵ San Francisco Department of Public Health, California.
⁶ Department of Epidemiology and Biostatistics, University at Albany School of Public Health, State University of New York.

Comment

Samuel M Jenness et al. Clin Infect Dis. 2018.

. 2018 Jun 18;67(1):155-156.

doi: 10.1093/cid/ciy050.

¹ Department of Epidemiology, Emory University, Atlanta, Georgia.
² Department of Anthropology, University of Washington, Seattle.
³ Division of STD Prevention and Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
⁴ Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia.
⁵ San Francisco Department of Public Health, California.
⁶ Department of Epidemiology and Biostatistics, University at Albany School of Public Health, State University of New York.

No abstract available

Comment on

Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study.
Jenness SM, Weiss KM, Goodreau SM, Gift T, Chesson H, Hoover KW, Smith DK, Liu AY, Sullivan PS, Rosenberg ES. Jenness SM, et al. Clin Infect Dis. 2017 Sep 1;65(5):712-718. doi: 10.1093/cid/cix439. Clin Infect Dis. 2017. PMID: 28505240 Free PMC article.
Risks of Antimicrobial Resistance in N. gonorrhoeae Associated with Intensive Screening Programs in Pre-Exposure Prophylaxis Programs.
Kenyon C. Kenyon C. Clin Infect Dis. 2018 Jun 18;67(1):154-155. doi: 10.1093/cid/ciy048. Clin Infect Dis. 2018. PMID: 29370373 No abstract available.

1. Kenyon C. Risks of antimicrobial resistance in N. gonorrhoeae associated with intensive screening programs in PrEP programmes. Clin Infect Dis 2018;67: 154–5. - PubMed
1. Jenness SM, Weiss KM, Goodreau SM et al. . Incidence of gonorrhea and chlamydia following human immunodeficiency virus preexposure prophylaxis among men who have sex with men: a modeling study. Clin Infect Dis 2017; 65:712–8. - PMC - PubMed
1. Kirkcaldy RD, Harvey A, Papp JR et al. . Neisseria gonorrhoeae antimicrobial susceptibility surveillance — The Gonococcal Isolate Surveillance Project, 27 sites, United States, 2014. MMWR Surveill Summ 2016; 65:1–19. - PubMed
1. Workowski KA, Bolan GA; Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64:1–137. - PMC - PubMed
1. Fung M, Scott KC, Kent CK, Klausner JD. Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex Transm Infect 2007; 83:304–9. - PMC - PubMed